Innovis Asset Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$485K Sell
35,410
-3,750
-10% -$55.2K 0.19% 67
2023
Q2
$676K Buy
39,160
+3,750
+11% +$76.7K 0.25% 57
2023
Q1
$850K Buy
35,410
+7,500
+27% +$163K 0.34% 53
2022
Q4
$484K Buy
+27,910
New +$588K 0.22% 72

Other funds holding CYRX

Innovis Asset Management's CYRX Position: Q3 2023 in Review

Innovis Asset Management reduced its CryoPort (CYRX) stake by 9.6% in Q3 2023, selling an estimated $55.2K and leaving 35,410 shares worth $485K. The position accounts for 0.19% of the portfolio, ranked #67.

Innovis Asset Management first reported a position in CYRX in Q4 2022 and has held it in 4 quarters since. The position peaked at $850K in Q1 2023. 159 funds tracked by Wall St. Rank hold CYRX as of Q3 2023.

  • Innovis Asset Management held 35,410 shares of CryoPort worth $485K as of Q3 2023.
  • Innovis Asset Management sold 3,750 CryoPort shares in Q3 2023, an estimated $55.2K.
  • CryoPort made up 0.19% of Innovis Asset Management's portfolio in Q3 2023, its #67 holding.
  • Innovis Asset Management first reported a position in CryoPort in Q4 2022 and has held it in 4 quarters since.
  • Innovis Asset Management's CryoPort position peaked at $850K in Q1 2023.
  • 159 funds tracked by Wall St. Rank held CryoPort as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.